Literature DB >> 34263156

Evaluation of Liposomal and Microbubbles Mediated Delivery of Doxorubicin in Two-Dimensional (2D) and Three-Dimensional (3D) Models for Breast Cancer.

Melek Aydın1, Ekrem Özdemir2, Zekiye Altun1, Sevgi Kılıç2, Safiye Aktaş1.   

Abstract

OBJECTIVE: Liposomal cancer treatment strategies are useful in removing the side effects that were the main concern in recent years. In this study, we prepared microbubble (MBs) conjugated with DOX-loaded liposomes (DOX-loaded MBs) and investigated their effectiveness in in vitro breast cancer cells in two dimensions (2D) and three dimensions (3D).
MATERIALS AND METHODS: With this aim, breast cancer cells with different features (4T1, MDA-MB231, MCF-7) were growth in 2D and 3D dimensions. The cytotoxic and cell death effects under different conditions, durations and doses were evaluated with WST-1, trypan-blue, colony counts. Apoptotic effects were investigated with flow cytometric Annexin-V-PI and immunohistochemical (Ki-67, caspase 3, 8, 9) methods.
RESULTS: After free DOX and LipoDOX were applied, the proliferation index of three cell lines reduced. Intrinsic and extrinsic apoptotic pathways were activated in both 2D and 3D models. However, this effect was observed at lower levels in the 3D model due to the difficulty of diffusion of DOX into the spheroids. Additionally, the suitability of the 3D model for breast cancer cells was supported by formation of ductus-like structures and spheroids. Cell deaths were not observed significantly with the DOX-loaded microbubbles due to rising of MBs to the surface and not reaching spheroids held in matrigel of 3D model.
CONCLUSION: DOX and LipoDOX showed anti-proliferative and apoptosis-inducing effects in breast cancer cells. However, these effects indicated variability depending on the cell lines and 2D or 3D model types. ©Copyright 2021 by Turkish Federation of Breast Diseases Associations.

Entities:  

Keywords:  3D cell culture; breast cancer; doxorubicin; liposome; microbubble

Year:  2021        PMID: 34263156      PMCID: PMC8246045          DOI: 10.4274/ejbh.galenos.2021.6255

Source DB:  PubMed          Journal:  Eur J Breast Health


  19 in total

1.  A new tandem peptide modified liposomal doxorubicin for tumor "ecological therapy".

Authors:  Ting Zhao; Hongli Zhou; Lei Lei; Chenqi Guo; Qin Yang; Ting Gong; Xun Sun; Xu Song; Tao Gong; Zhirong Zhang
Journal:  Nanoscale       Date:  2020-01-27       Impact factor: 7.790

Review 2.  The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer.

Authors:  Britta Weigelt; Cyrus M Ghajar; Mina J Bissell
Journal:  Adv Drug Deliv Rev       Date:  2014-01-09       Impact factor: 15.470

3.  Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery.

Authors:  Michael C Cochran; John Eisenbrey; Richard O Ouma; Michael Soulen; Margaret A Wheatley
Journal:  Int J Pharm       Date:  2011-05-13       Impact factor: 5.875

4.  New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization.

Authors:  Steliyan Tinkov; Conrad Coester; Susanne Serba; Nicolas A Geis; Hugo A Katus; Gerhard Winter; Raffi Bekeredjian
Journal:  J Control Release       Date:  2010-09-22       Impact factor: 9.776

5.  Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up.

Authors:  Bhavana Pothuri; Allison L Brodsky; Joseph A Sparano; Stephanie V Blank; Mimi Kim; Dawn L Hershman; Amy Tiersten; Brian F Kiesel; Jan H Beumer; Leonard Liebes; Franco Muggia
Journal:  Cancer Chemother Pharmacol       Date:  2020-02-13       Impact factor: 3.333

Review 6.  Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies.

Authors:  David A Mahvi; Rong Liu; Mark W Grinstaff; Yolonda L Colson; Chandrajit P Raut
Journal:  CA Cancer J Clin       Date:  2018-10-17       Impact factor: 508.702

7.  A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro.

Authors:  Janet Myungjin Lee; Paulette Mhawech-Fauceglia; Nathan Lee; Lucineh Cristina Parsanian; Yvonne Gail Lin; Simon Andrew Gayther; Kate Lawrenson
Journal:  Lab Invest       Date:  2013-03-04       Impact factor: 5.662

8.  Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer.

Authors:  Dinglingge Cao; Xingxian Zhang; M D Akabar; Yuan Luo; Hao Wu; Xue Ke; Tianyuan Ci
Journal:  Artif Cells Nanomed Biotechnol       Date:  2019-12       Impact factor: 5.678

9.  Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers.

Authors:  Fei Yan; Lu Li; Zhiting Deng; Qiaofeng Jin; Juanjuan Chen; Wei Yang; Chih-Kuang Yeh; Junru Wu; Robin Shandas; Xin Liu; Hairong Zheng
Journal:  J Control Release       Date:  2013-01-07       Impact factor: 9.776

10.  Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation.

Authors:  Maria Vinci; Sharon Gowan; Frances Boxall; Lisa Patterson; Miriam Zimmermann; William Court; Cara Lomas; Marta Mendiola; David Hardisson; Suzanne A Eccles
Journal:  BMC Biol       Date:  2012-03-22       Impact factor: 7.431

View more
  2 in total

1.  Impact of Doxorubicin on Cell-Substrate Topology.

Authors:  Andreas Krecsir; Verena Richter; Michael Wagner; Herbert Schneckenburger
Journal:  Int J Mol Sci       Date:  2022-06-03       Impact factor: 6.208

Review 2.  Ultrasound and Nanomedicine for Cancer-Targeted Drug Delivery: Screening, Cellular Mechanisms and Therapeutic Opportunities.

Authors:  Chien-Hsiu Li; Yu-Chan Chang; Michael Hsiao; Ming-Hsien Chan
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.